Over the past decade or so, there has been a massive shift in cancer research toward discovering more targeted therapeutic alternatives to chemotherapy and radiation. Subscribing to this approach, Professor Virna Leaner, head of the Division of Medical Biochemistry at UCT, and her group of researchers have dedicated their academic work to looking for novel cancer biomarkers that could serve as therapeutic targets.
The rising incidence of cancer in Africa coupled with the spiralling prices of leading therapies indicates that there is a great need for locally developed immune-oncology diagnostics and therapeutics. Following 20 years of work in the fields of medical biotechnology and immunotherapy in Germany, Professor Stefan Barth was recruited by the Department of Science and Technology/National Research Foundation’s South African Research Chair (SARChI) in 2015 to lead the Tier 1 Chair in Cancer Biotechnology at UCT.
RC&I hosted two events for Student Entrepreneurship Week (SEW) 2018 on 29 August. The highlight of these events was the launch of the UCT Innovation Ecosystem Map which clearly represents the spatial arrangement of incubators, accelerators and UCT Spin-Off companies relative to each other.
University of Cape Town (UCT) professors Kelly Chibale, Virna Leaner and Kevin Naidoo have been honoured among 20 of South Africa’s leading scholars and scientists inaugurated as Members of the Academy of Science of South Africa (ASSAf).